The selective inhibition of ROCK2 is particularly strong due to its high affinity for the enzyme, making it a valuable tool for studying ROCK2 function in research and in potential therapeutic applications, including for Alzheimer’s disease and the regulation of tau protein levels [52]. Here, MAPT is linked to early-onset autosomal dominant Alzheimer disease.